| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2014 | US8778922 Steroidal compositions |
| 07/15/2014 | US8778921 Ansamycin hydroquinone compositions |
| 07/15/2014 | US8778920 3-cyano-quinoline derivatives with antiproliferative activity |
| 07/15/2014 | US8778919 Cyclic anilino—pyridinotriazines |
| 07/15/2014 | US8778918 Use of 19 nor DHEA derivatives for enhancing physical performance |
| 07/15/2014 | US8778917 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 07/15/2014 | US8778916 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
| 07/15/2014 | US8778915 Method for the treatment of central nervous system cancers and compositions related thereto |
| 07/15/2014 | US8778914 Bisphosphonate-prodrugs |
| 07/15/2014 | US8778913 Antimicrobial compositions for treating microbial infections |
| 07/15/2014 | US8778912 Composition of dialysis liquid comprising crystallisation inhibitor substances |
| 07/15/2014 | US8778911 Use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 07/15/2014 | US8778909 Method of applying an injectable filler |
| 07/15/2014 | US8778908 Cystitis treatment with high dose chondroitin sulfate |
| 07/15/2014 | US8778907 Lactulose for bowel evacuation |
| 07/15/2014 | US8778906 Modulation of line-1 reverse transcriptase |
| 07/15/2014 | US8778904 Methods and compositions for treating diseases, disorders or injury of the CNS |
| 07/15/2014 | US8778902 RNA interference mediating small RNA molecules |
| 07/15/2014 | US8778898 Oligomer conjugates of heteropentacyclic nucleosides |
| 07/15/2014 | US8778897 Method of treatment using α-1-adrenergic agonist compounds |
| 07/15/2014 | US8778896 Levoisovalerylspiramycin I, II or III, preparations, preparation methods and uses thereof |
| 07/15/2014 | US8778894 Luteolin and diosmin/diosmetin as novel STAT3 inhibitors for treating autism |
| 07/15/2014 | US8778892 Compounds and methods for treatment of solid tumors |
| 07/15/2014 | US8778885 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 07/15/2014 | US8778882 Agent for strengthening calcium containing tissue and use thereof |
| 07/15/2014 | US8778876 Small-molecule inhibitors of Dengue and West Nile virus proteases |
| 07/15/2014 | US8778873 Parenteral combination therapy for infective conditions with drug resistant bacterium |
| 07/15/2014 | US8778868 Chemically defined vaccine stabiliser |
| 07/15/2014 | US8778837 Use of active substance combinations for controlling animal pests |
| 07/15/2014 | US8778671 Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus |
| 07/15/2014 | US8778628 Arylalkylamine compound and process for preparing the same |
| 07/15/2014 | US8778421 Herpes treatment |
| 07/15/2014 | US8778419 Composition for use in the prevention and treatment of cardiovascular diseases |
| 07/15/2014 | US8778412 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 07/15/2014 | US8778410 Oral or enteral composition useful for recovery of physical functions |
| 07/15/2014 | US8778406 Anti-chafing aerosol powder |
| 07/15/2014 | US8778404 Nutritional compositions |
| 07/15/2014 | US8778400 Nanoparticle-stabilized capsule formulation for treatment of inflammation |
| 07/15/2014 | US8778397 Stabilized tolterodine tartrate formulations |
| 07/15/2014 | US8778396 Multi-unit gastroretentive pharmaceutical dosage form comprising microparticles |
| 07/15/2014 | US8778395 Diltiazem controlled release formulation and method of manufacture |
| 07/15/2014 | US8778394 Small-volume oral transmucosal dosage forms |
| 07/15/2014 | US8778393 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
| 07/15/2014 | US8778392 Oral disintegrating tablet |
| 07/15/2014 | US8778391 Flurbiprofen and muscle relaxant combinations |
| 07/15/2014 | US8778390 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 07/15/2014 | US8778389 Medicament for the treatment of fungal infections particularly aspergillosis |
| 07/15/2014 | US8778385 Medicated animal food composition |
| 07/15/2014 | US8778382 Tamper resistant transdermal dosage form |
| 07/15/2014 | US8778373 Methods for controlled release oral dosage of a vitamin D compound |
| 07/15/2014 | US8778367 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications |
| 07/15/2014 | US8778366 Enalapril compositions |
| 07/15/2014 | US8778365 Topical compositions and methods for making and using same |
| 07/15/2014 | US8778356 Vaccine |
| 07/15/2014 | US8778325 Water-soluble and biodegradable antimicrobial agent |
| 07/15/2014 | US8778324 Ion binding polymers and uses thereof |
| 07/15/2014 | US8778323 Cosmetic compositions containing block copolymers, tackifiers and modified silicones |
| 07/15/2014 | US8778322 pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
| 07/15/2014 | US8778316 Non-sticky, hydrating and moisturizing aqueous lip gloss composition |
| 07/15/2014 | US8778315 Melanin modification compositions and methods of use |
| 07/15/2014 | US8778301 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/15/2014 | US8778298 Isotope labeled 2-arylpropionic acid compounds and process for production of same, and molecular probe for positron emission tomography and method for imaging of cyclooxygenase and the like using same |
| 07/15/2014 | US8777134 Suspension comprising benzimidazole carbamate and a polysorbate |
| 07/15/2014 | CA2800946C Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same |
| 07/15/2014 | CA2782510C Polypeptides |
| 07/15/2014 | CA2770486C Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| 07/15/2014 | CA2753434C Soluble guanylate cyclase activators |
| 07/15/2014 | CA2753304C Tricyclic pyrazolopyrimidine derivatives as hsp inhibitors |
| 07/15/2014 | CA2752550C Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 07/15/2014 | CA2745004C Pyridine-3-carboxyamide derivative |
| 07/15/2014 | CA2707299C Use of rr/sr-ractopamine |
| 07/15/2014 | CA2694925C Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function |
| 07/15/2014 | CA2686489C Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 07/15/2014 | CA2682347C A medicament for treating schizophrenia comprising cilostazol |
| 07/15/2014 | CA2674460C 3-substituted-h.2.31-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| 07/15/2014 | CA2659353C Composition and method for treatment of tumors |
| 07/15/2014 | CA2659322C Compositions containing quaternary ammonium compounds |
| 07/15/2014 | CA2650833C Autodestructive transdermal therapeutic system |
| 07/15/2014 | CA2648303C 5-[monocyclic(hetero)arylsubstituted-1,2,4-oxadliazol-3-yl]-(fused heteroaryl substituted) compounds and their use as s1p1 agonists |
| 07/15/2014 | CA2643270C Pharmaceutical composition and functional food for suppressing and relieving itching and inflammation |
| 07/15/2014 | CA2635760C Modulators of atp-binding cassette transporters |
| 07/15/2014 | CA2635231C Protein kinase inhibitors |
| 07/15/2014 | CA2634555C Diazepinones |
| 07/15/2014 | CA2622021C Composition comprising a dendrimer and the use thereof for binding phosphate |
| 07/15/2014 | CA2617546C Use of flibanserin in the treatment of obesity |
| 07/15/2014 | CA2617256C Cyclic amine compound |
| 07/15/2014 | CA2608061C Pharmaceutical composition including an anti-tumoral and an active ingredient selected among carveol, thymol, eugenol, borneol and carvacrol |
| 07/15/2014 | CA2606887C Pharmaceutical composition |
| 07/15/2014 | CA2603385C Desferrithiocin polyether analogues and uses thereof for treating metal overload, oxidative stress, and neoplastic and preneoplastic conditions |
| 07/15/2014 | CA2600890C Salts, addition compounds and complex compounds of guanidinoacetic acid |
| 07/15/2014 | CA2598995C Dimeric iap inhibitors |
| 07/15/2014 | CA2595607C Substituted arylamine compounds and their use as 5-ht6 modulators |
| 07/15/2014 | CA2592119C Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 07/15/2014 | CA2592086C Mixture of a vanilloid receptor agonist and a substance inhibiting nerve regeneration, use thereof for producing a painkiller, and method for applying said painkiller |
| 07/15/2014 | CA2584481C Pharmaceutical compositions based on nk2 antagonists for pediatric use |
| 07/15/2014 | CA2584185C Heterocyclic substituted bisarylurea derivates as kinase inhibitors |
| 07/15/2014 | CA2574121C Antiviral compounds |
| 07/15/2014 | CA2565421C Synergism of gos and polyfructose |
| 07/15/2014 | CA2563959C (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors |
| 07/15/2014 | CA2561082C Anti-inflammatory treatment based on strontium compounds |